Navigation Links
Corgenix Receives Additional European Patent, Announces Publication of Important Clinical Study on AtherOx(R) Technology
Date:6/22/2010

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for vascular diseases, immunology disorders, and bone and joint disorders, including the world's only non-blood-based test for aspirin effect. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 52 diagnostic products through a global distribution network. More information is available at www.corgenix.com.

Statements in this press release that are not strictly historical facts are "forward-looking" statements (identified by the words "believe", "estimate", "project", "expect" or similar expressions) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the company's products and services in the marketplace, competitive factors, changes in the regulatory environment, and other risks detailed in the company's periodic report filings with the Securities and Exchange Commission. The statements in this press release are made as of today, based upon information currently known to management, and the company does not undertake any obligation to publicly update or revise any forward-looking statements.


'/>"/>
SOURCE Corgenix Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Corgenix to Exhibit AspirinWorks(R) Test at Pri-Med New York
2. Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents
3. Corgenix Secures $1,750,000 Asset Based Credit Facility Representing Initial Gross Proceeds of $1.109 Million
4. Corgenix Reports Third Quarter Fiscal 2009 Financial Results
5. Corgenix to Exhibit AspirinWorks(R) Test at ACC.09
6. Corgenix Reports Second Quarter Fiscal 2009 Financial Results
7. Corgenix to Host Conference Call to Discuss Second Quarter Results
8. Corgenix Signs Collaboration With Battelle
9. Corgenix Receives Two Additional Patents on AtherOx(R) Technology
10. Corgenix to Host Conference Call to Discuss First Quarter Results
11. Corgenix to Exhibit AspirinWorks(R) Test, Discuss New CHARISMA Trial Results at AHA 2008 Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... , Dec. 22, 2014  Alternative Energy & ... it has signed a letter of intent to ... developed and patented a nanotechnology-based development platform used ... that enable rapid on-site collection and testing to ... health issues in an immediate, non-invasive and cost-effective ...
(Date:12/22/2014)... The American Journal of Hematology/Oncology, ... reviews and editorials addressing developments and pathways related ... a provocative article exploring the role of follicle-stimulating ... treatment of prostate cancer. , The article ... possibility that there could be a connection to ...
(Date:12/19/2014)... Hershey, PA (PRWEB) December 19, 2014 ... a leading developer and manufacturer of needle-free injection ... an agreement with Immunomic Therapeutics, Inc. (“ITI”) for ... injection device with its LAMP™ vaccine platform. ... for an exclusive Worldwide license to the Biojector®-2000 ...
(Date:12/19/2014)... Dec. 19, 2014 Naurex Inc., a biopharmaceutical ... for diseases of the central nervous system, today announced ... executive officer, will present at the 33 rd ... take place at 3:00 p.m. PST on Tuesday, January ... San Francisco, Calif. ...
Breaking Biology Technology:ALNE Announces Intention To Acquire BioTechPharma 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2
... Life Technologies Corporation (NASDAQ: LIFE ) ... Stock Conference on Tuesday, May 10 at 9:45am CT. ... will present on behalf of the company. The company ... three weeks following the conference on the Life Technologies, ...
... Here, Inc., and Richards Partners have been selected ... a wholly owned subsidiary of International Stem Cell ... on therapeutic and research products.  Lifeline offers luxury ... stem cell technology.  Based in Dallas and part ...
... promise of superfast computers and ultrapowerful optical microscopes ... of the hottest fields in high-technology. However, to ... that feature interfaces between noble metals and dielectrics. ... (DOE),s Lawrence Berkeley National Laboratory (Berkeley Lab) have ...
Cached Biology Technology:Life Technologies to Present at Baird's 2011 Growth Stock Conference 2Lifeline Skin Care™ Selects Click Here, Inc., Richards Partners 2Lifeline Skin Care™ Selects Click Here, Inc., Richards Partners 3New kid on the plasmonic block 2New kid on the plasmonic block 3New kid on the plasmonic block 4New kid on the plasmonic block 5
(Date:12/22/2014)... 2014  The 2014 Holiday Season may be ... Acuity Market Intelligence reports that the long anticipated ... Acuity forecasts that intensifying demand for smart phones, ... will drive a global market of 2.5 billion ... 2020.   According to Maxine ...
(Date:12/17/2014)... DUBLIN , Dec. 15, 2014 Research ... announced the addition of the "Samsung Galaxy ... Analysis" report to their offering. ... on a totally different sensing technology than the ... a fingerprint sensor in its product. ...
(Date:12/17/2014)...  Automation is fundamentally transforming the travel experience ... international borders. Over the past decade, ePassports, biometric ... travelers to self process through border control via ... an increasing number of airports, seaports, and land ... to Maxine Most , Principal at Acuity ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... kill bacteria could be making them stronger, according to ... journal Microbiology . Low levels of these chemicals, ... aureus remove toxic chemicals from the cell even more ... some antibiotics. Biocides are used in disinfectants and ...
... Top 100 Internet Retailers, BOISE, Idaho, Oct. ... provider of fraud control for ecommerce merchants, has ... National Account Sales,directors. Together, they bring Kount customers ... ecommerce fraud control and online,payments., Scott Lewer ...
... New Haven, Conn. Yale researchers have harnessed the power ... in 1916 that plants with rapid reproductive cycles evolve ... Science . "Our study has profound consequence for ... of the computer in revealing major evolutionary patterns," said senior ...
Cached Biology News:Disinfectants can make bacteria resistant to treatment 2Kount Lands Veteran Fraud Experts From Retail Decisions and iovation 2Reproducing early and often is the key to rapid evolution in plants 2
Umbilical cord blood CD14+ Monocytes, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Umbilical cord blood basophils, For immunohistochemistry (IHC)...
Human peripheral blood neutrophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Human peripheral blood CD14+ monocytes, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Biology Products: